ACM
CLCD

Atika Capital Management’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Atika Capital Management’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-68,400
Closed -$2.49M – 83
2016
Q4 		$2.49M Sell
68,400
-6,600
-9% -$234K 1.48% 27
2016
Q3 		$2.86M Buy
+75,000
New +$1.11M 1.17% 32

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Atika Capital Management's CLCD Position: Q1 2017 in Review

Atika Capital Management sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 68,400 shares — an estimated $2.49M sold.

Atika Capital Management first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $2.86M in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • Atika Capital Management reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Atika Capital Management sold 68,400 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $2.49M.
  • Atika Capital Management first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
  • Atika Capital Management's CoLucid Pharmaceuticals, Inc. position peaked at $2.86M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Atika Capital Management's 13F filing for Q1 2017, filed 15 May 2017.